Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias is a research paper published in New England Journal of Medicine (2012). On theSindex it has a DataRank of 0.998. It has been cited 773 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.998
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: P30 CA069533
NCI NIH HHS
Grant: P01 CA049639
NCI NIH HHS
Grant: R37 CA065823
NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: CA016672
FWCI
44.50
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals